Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
Mutations in the NF1 gene lead to neurofibromatosis type 1, which often leads to bone abnormalities and spine deformity. Efforts to treat or even prevent the disease have been stymied by lack of ...
Morning Overview on MSN
Discovery could one day reverse osteoporosis, scientists say
For decades, osteoporosis has meant a slow, one way slide toward fragile bones and fracture risk, managed but rarely truly ...
Organoids cultured on a bone scaffold created a vascularized model of the human endosteal niche, paving the way for more ...
Celebrated photographer Dayanita Singh shows images that spanning over four decades of photographing the late legendary tabla maestro Zakir Hussain ...
News-Medical.Net on MSN
Hypertrophic chondrocytes play a crucial role in bone growth and repair
Normal, regulated growth of skeletal bones is a crucial part of the growth of mammals. This is a complex process involving ...
Hypertrophic chondrocytes are deeply involved in the growth of mammalian bones. Researchers find that these cells transform into multiple functional cell types, including those responsible for ...
In the United States alone, over 50 million people deal with the complications of osteoporosis. While it's more common in people over 50, you can show symptoms earlier, especially since the human body ...
A newly discovered receptor switch that boosts bone growth could transform how we treat osteoporosis, by stimulating the body’s own bone-building machinery using a targeted drug and even mechanical ...
Estrogen plays an important role in keeping bones healthy. Now, researchers investigated how membrane-initiated estrogen receptor alpha (mERα) signaling in specific cell types of female mice affects ...
Scientists have identified a protein that blocks the activity of bone-forming cells (osteoblasts) by stopping them from maturing during the journey to sites of bone formation, a new study has found.
Scientists have identified a protein that blocks the activity of bone-forming cells (osteoblasts) by stopping them from maturing during the journey to sites of bone formation, a new study has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results